Featured White Papers
Health Care Industry
Industry: Email Alert RSS FeedDiagnosis and therapy of chronic systemic co-infections in Lyme disease and other tick-borne infectious diseases
Townsend Letter for Doctors and Patients, April, 2007 by Garth L. Nicolson
Professor Garth L. Nicolson is the President, Chief Scientific Officer and Research Professor at the Institute for Molecular Medicine in Huntington Beach, California. Born in 1943 in Los Angeles, Dr. Nicolson received his BS in Chemistry from University of California at Los Angeles in 1965 and his PhD in Biochemistry and Cell Biology from the University of California at San Diego in 1970. He is currently Professor of Integrative Medicine at Capitol University of Integrative Medicine and a Conjoint Professor at the University of Newcastle (Australia). He was formally the David Bruton Jr. Chair in Cancer Research and Professor and Chairman of the Department of Tumor Biology at the University of Texas M. D. Anderson Cancer Center in Houston, and he was Professor of Internal Medicine and Professor of Pathology and Laboratory Medicine at the University of Texas Medical School at Houston. He was also Professor of Comparative Pathology at Texas A & M University. Professor Nicolson has published over 580 medical and scientific papers (including three Current Contents Citation Classics), edited 14 books and served on the Editorial Boards of 20 medical and scientific journals. Professor Nicolson has won many awards, such as the Burroughs Wellcome Medal of the Royal Society of Medicine (United Kingdom), Stephen Paget Award of the Metastasis Research Society, the US National Cancer Institute Outstanding Investigator Award, and the Innovative Medicine Award of Canada. He is also a Colonel (Honorary) of the US Army Special Forces and a US Navy SEAL (Honorary) for his work on Armed Forces and veterans' illnesses.
[ILLUSTRATION OMITTED]
Table 1. Treatment of Lyme Disease During the Different Stages of the
Disease (12,13)
Clinical Stage Time Primary Treatment Alternative Treatment
Early localized 3-30 days doxycycline erythromycin
amoxcillin clarithromycin
cefuroxime axetil azithromycin
Early disseminated 1-12 wks doxycycline erythromycin
amoxcillin clarithromycin
cefuroxime axetil azithromycin
with CNS ceftriaxone (iv) penicillin G (iv)
involvement doxycycline (iv or po)
Late disseminated >2 months
with arthritis amoxcillin penicillin G (iv)
doxycycline doxycycline (iv or po)
with CNS ceftriaxone (iv) penicillin G (iv)
involvement doxycycline (iv or po)
with cardiac ceftriaxone (iv)
involvement amoxcillin
Table 2. Combination Treatments for Lyme Borrelia Plus Co-
Infections (17)
Mycoplasma/
Lyme Borrelia Ehrlichia Bartonella Babesia
Amox+Probenecid+ +Doxycycline +Septra +Mepron
Macrolide+Plaquenil +Malarone
[+ or -]Flagyl/Tinidazole +Lariam
Bicillin+Macrolide+ +Doxycycline +Septra +Mepron
Plaquenil +Malarone
[+ or -]Flagyl/Tinidazole +Artemesia
+Lariam
Cephalosporin (po/iv)+ +Doxycycline +Septra +Mepron
Macrolide+Plaquenil +Malarone
[+ or -]Flagyl/Tinidazole +Artemesia
+Lariam
Doxycycline+ +Ciprofloxacin +Septra +Lariam
Plaquenil +Rifampin +Malarone
[+ or -]Flagyl/Tinidazole +Artemesia
Macrolide+Plaquenil +Doxycycline +Septra +Mepron
[+ or -]Flagyl/Tinidazole +Quinolone +Malarone
+Artemesia
+Lariam
COPYRIGHT 2007 The Townsend Letter Group
COPYRIGHT 2007 Gale Group